Oral remibrutinib hits Phase 3 primary endpoint for inducible hives
1. Oral remibrutinib successfully met its primary endpoint in the Phase III RemIND trial, delivering significant symptom relief for chronic ...
Tag: urticaria
![2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]](https://www.2minutemedicine.com/wp-content/uploads/2025/05/ChatGPT-Image-May-12-2025-at-10_22_23-AM-350x250.png)
2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
Drugmakers Increase Prices on Over 250 Medications Pharmaceutical companies have raised prices on over 250 branded medications in the U.S., ...
Safety of investigational vaccines against human immunodeficiency virus
1. In this phase 1 randomized controlled trial, urticaria was reported in several participants who received a messenger RNA vaccine ...
#VisualAbstract: Remibrutinib Relieves Itching and Hives in Chronic Spontaneous Urticaria
Click here to read this study in NEJM. ©2025 2 Minute Medicine, Inc. All rights reserved. No works may be ...
Patient Basics: Hives (Urticaria)
Originally published by Harvard Health. What Is It? Hives, also called urticaria, are circumscribed swellings on the skin that often ...
Single course intravenous immunoglobulin ineffective at controlling severe solar urticaria
1. Out of 9 patients with severe solar urticaria (SU) who received a single-dose of intravenous immunoglobulin (IVIG), 2 showed ...
Omalizumab relieves symptoms in chronic idiopathic urticaria
Image: PD 1. Omalizumab alleviated itchiness and reduced hives in patients with chronic idiopathic urticaria refractory to H1-antihistamine therapy. 2. ...
